Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Metabolic Muscular Biomarkers in Pompe Disease - a Non-invasive

NCT05943678 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT05943678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05943678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Metabolic Muscular Biomarkers in Pompe Disease - a Non-invasive
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Active, not recruiting
Start date
August 15, 2023
Completion date
October 15, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mcardle disease, pompe disease